← Leaderboards
Daniel Jane-Wit
Va Connecticut Healthcare System
$3,884,549
Attributed
$3,884,549
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $885.1K · FY2015–24$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,884,549 · 4
VA$0 · 1
By mechanism
R01$2,560,150 · 1
R00$731,879 · 1
R21$460,625 · 1
K99$131,895 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Complement”
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$128,874,888
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Steve Riordan · Westat, Inc.$94,143,268
- David R. Weir · University Of Michigan At Ann Arbor$93,718,087
- Stuart L Schreiber · Harvard University (Medical School)$88,512,978
Research focus
ComplementIn VitroSignal TransductionIn VivoComplement Membrane Attack ComplexEndothelial CellsMediatingProteinsTransplantationHost DefenseSpecimenMouse ModelPathway InteractionsCd4 Positive T LymphocytesBaseInflammatoryClinically RelevantImmuneT-LymphocyteCell DeathHumanized MouseTissuesCell SurfaceLesion
Grant awards (17)
Intracellular Membrane Attack Complexes and COVID-19 Immune Hyperactivation$209,375
R21 · FY2024 · AI · contact PI
Hedgehog-Induced Activation of Alloimmune T Cells During Ischemia Reperfusion Injury$0
I01 · FY2024 · VA · contact PI
Intracellular Membrane Attack Complexes and COVID-19 Immune Hyperactivation$251,250
R21 · FY2023 · AI · contact PI
Hedgehog-Induced Activation of Alloimmune T Cells During Ischemia Reperfusion Injury$0
I01 · FY2023 · VA · contact PI
Complement-Induced Endothelial Cell Activation by a Novel Rab5-ZFYVE21-SMURF2 Signaling Axis$418,750
R01 · FY2022 · HL · contact PI
Hedgehog-Induced Activation of Alloimmune T Cells During Ischemia Reperfusion Injury$0
I01 · FY2022 · VA · contact PI
Complement-Induced Endothelial Cell Activation by a Novel Rab5-ZFYVE21-SMURF2 Signaling Axis$418,750
R01 · FY2021 · HL · contact PI
THE ROLE OF ZFYVE21 IN CEREBRAL AMYLOID ANGIOPATHY IN ALZHEIMER'S DISEASE$384,362
R01 · FY2021 · HL · contact PI
Complement-Induced Endothelial Cell Activation by a Novel Rab5-ZFYVE21-SMURF2 Signaling Axis$82,038
R01 · FY2021 · HL · contact PI
Hedgehog-Induced Activation of Alloimmune T Cells During Ischemia Reperfusion Injury$0
I01 · FY2021 · VA · contact PI
Complement-Induced Endothelial Cell Activation by a Novel Rab5-ZFYVE21-SMURF2 Signaling Axis$418,750
R01 · FY2020 · HL · contact PI
Complement-Induced Endothelial Cell Activation by a Novel Rab5-ZFYVE21-SMURF2 Signaling Axis$418,750
R01 · FY2019 · HL · contact PI
Mechanisms of Non-Canonical NF-kB Activation in Transplant Arteriosclerosis$238,870
R00 · FY2019 · HL · contact PI
Complement-Induced Endothelial Cell Activation by a Novel Rab5-ZFYVE21-SMURF2 Signaling Axis$418,750
R01 · FY2018 · HL · contact PI
Mechanisms of Non-Canonical NF-kB Activation in Transplant Arteriosclerosis$244,009
R00 · FY2018 · HL · contact PI
Mechanisms of Non-Canonical NF-kB Activation in Transplant Arteriosclerosis$249,000
R00 · FY2017 · HL · contact PI
Mechanisms of Non-Canonical NF-kB Activation in Transplant Arteriosclerosis$131,895
K99 · FY2015 · HL · contact PI